166 related articles for article (PubMed ID: 21857231)
1. Feasibility of a pancreatic cancer surveillance program from a psychological point of view.
Harinck F; Nagtegaal T; Kluijt I; Aalfs C; Smets E; Poley JW; Wagner A; van Hooft J; Fockens P; Bruno M; Bleiker EM
Genet Med; 2011 Dec; 13(12):1015-24. PubMed ID: 21857231
[TBL] [Abstract][Full Text] [Related]
2. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.
Konings IC; Sidharta GN; Harinck F; Aalfs CM; Poley JW; Kieffer JM; Kuenen MA; Smets EM; Wagner A; van Hooft JE; van Rens A; Fockens P; Bruno MJ; Bleiker EM
Psychooncology; 2016 Aug; 25(8):971-8. PubMed ID: 26632416
[TBL] [Abstract][Full Text] [Related]
3. The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis.
Paiella S; Marinelli V; Secchettin E; Mazzi MA; Ferretto F; Casolino R; Bassi C; Salvia R
Psychooncology; 2020 Jun; 29(6):1004-1011. PubMed ID: 32108397
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.
Konings IC; Harinck F; Kuenen MA; Sidharta GN; Kieffer JM; Aalfs CM; Poley JW; Smets EM; Wagner A; van Rens A; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ; Bleiker EM;
Fam Cancer; 2017 Jan; 16(1):143-151. PubMed ID: 27629874
[TBL] [Abstract][Full Text] [Related]
5. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.
Maheu C; Vodermaier A; Rothenmund H; Gallinger S; Ardiles P; Semotiuk K; Holter S; Thayalan S; Esplen MJ
Fam Cancer; 2010 Dec; 9(4):617-24. PubMed ID: 20623197
[TBL] [Abstract][Full Text] [Related]
7. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
8. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance.
Overbeek KA; Cahen DL; Kamps A; Konings ICAW; Harinck F; Kuenen MA; Koerkamp BG; Besselink MG; van Eijck CH; Wagner A; Ausems MGE; van der Vlugt M; Fockens P; Vleggaar FP; Poley JW; van Hooft JE; Bleiker EMA; Bruno MJ;
Fam Cancer; 2020 Jul; 19(3):247-258. PubMed ID: 32193697
[TBL] [Abstract][Full Text] [Related]
10. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program.
O'Neill RS; Meiser B; Emmanuel S; Williams DB; Stoita A
Fam Cancer; 2020 Jan; 19(1):23-35. PubMed ID: 31625003
[TBL] [Abstract][Full Text] [Related]
11. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
12. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
14. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial.
Gangi A; Malafa M; Klapman J
Pancreas; 2018; 47(5):586-591. PubMed ID: 29683970
[TBL] [Abstract][Full Text] [Related]
16. Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer.
Harinck F; Poley JW; Kluijt I; Fockens P; Bruno MJ;
Dig Dis; 2010; 28(4-5):670-8. PubMed ID: 21088419
[TBL] [Abstract][Full Text] [Related]
17. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
18. Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.
Lorenzo D; Rebours V; Maire F; Palazzo M; Gonzalez JM; Vullierme MP; Aubert A; Hammel P; Lévy P; de Mestier L
World J Gastroenterol; 2019 Sep; 25(34):5082-5096. PubMed ID: 31558858
[TBL] [Abstract][Full Text] [Related]
19. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
20. Health behaviours and beliefs in individuals with familial pancreatic cancer.
Underhill-Blazey M; Blonquist T; Lawrence J; Hong F; Yurgelun MB; Syngal S
Fam Cancer; 2019 Oct; 18(4):457-464. PubMed ID: 31522335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
